Human Blood-Derived Products Having Decreased Fibrinolytic Activity And Uses Thereof In Hemostatic Disorders - EP3506915

The patent EP3506915 was granted to Plas Free on Mar 6, 2024. The application was originally filed on Aug 31, 2017 under application number EP17768525A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3506915

PLAS FREE
Application Number
EP17768525A
Filing Date
Aug 31, 2017
Status
Granted And Under Opposition
Feb 2, 2024
Grant Date
Mar 6, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

BIOTESTDec 5, 2024TER MEER STEINMEISTER & PARTNERADMISSIBLE
MARCHANTDec 4, 2024MURGITROYDADMISSIBLE

Patent Citations (26) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS3998946
DESCRIPTIONUS7125569
INTERNATIONAL-SEARCH-REPORTEP0156496
INTERNATIONAL-SEARCH-REPORTUS2003124703
INTERNATIONAL-SEARCH-REPORTUS2016058937
INTERNATIONAL-SEARCH-REPORTUS4578056
INTERNATIONAL-SEARCH-REPORTWO0137900
INTERNATIONAL-SEARCH-REPORTWO02072234
INTERNATIONAL-SEARCH-REPORTWO02095019
INTERNATIONAL-SEARCH-REPORTWO03007873
INTERNATIONAL-SEARCH-REPORTWO03039588
INTERNATIONAL-SEARCH-REPORTWO2013001524
INTERNATIONAL-SEARCH-REPORTWO2013070809
OPPOSITIONEP0286323
OPPOSITIONEP1568709
OPPOSITIONEP3727483
OPPOSITIONUS2003124703
OPPOSITIONUS2013001524
OPPOSITIONUS2015238529
OPPOSITIONUS7550567
OPPOSITIONUS9534012
OPPOSITIONWO2010094901
OPPOSITIONWO2014085861
OPPOSITIONWO2019167048
OPPOSITIONWO9305067
OPPOSITIONWO9525748

Non-Patent Literature (NPL) Citations (12) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- Anonymous, "Plasminogen Removal Gel", Omrix Product Information Sheet, (20121201), pages 1 - 2, XP093272183-
OPPOSITION- Blombäck Birger , Margareta Blombäck, "Proceedings of the Swedish Biochemical Society", ACTA chemica scandinavica, (19560101), vol. 10, no. 1, pages 147 - 147, XP093195195-
OPPOSITION- D22: Analytical Assessment of the product according to the invention-
OPPOSITION- D23: Quantification of alpha 2-anti-plasmin in the product according to the invention-
OPPOSITION- G. A. W. de Munk; M. P. M. Caspers; G. T. G. Chang; P. H. Pouwels; B. E. Enger-Valk; J. H. Verheijen, "Binding of Tissue-Type Plasminogen Activator to Lysine, Lysine Analogues, and Fibrin Fragments", Biochemistry, (19890101), vol. 28, pages 7318 - 7325, XP001317644-
OPPOSITION- McLeod, B.C., "Therapeutic apheresis: use of human serum albumin, fresh frozen plasma and cryosupernatant plasma in therapeutic plasma exchange", Best Practice & Research Clinical Haematology, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , (20060301), vol. 19, no. 1, ISSN 1521-6926, pages 157 - 167, XP005219067-
OPPOSITION- Sparrow Rosemary L., Simpson Richard J., Greening David W., "A Protocol for the Preparation of Cryoprecipitate and Cryo-depleted Plasma for Proteomic Studies : Methods and Protocols", Serum/Plasma Proteomics : Methods and Protocols, Springer New York, (20170101), pages 23 - 30, doi:10.1007/978-1-4939-7057-5_2, ISSN 1064-3745, ISBN 978-1-4939-7057-5, XP093272177
OPPOSITION- Bjern-lvar Haukanes , Catrlne Kvam, "Application of magnetic beads in bioassays ", Biotechnology, US , (19930101), vol. 11, no. 1, doi:10.1038/nbt0193-60, ISSN 0733-222X, pages 60 - 63, XP000609039
OPPOSITION- Klingel Reinhard, Fassbender Cordula, Fassbender Thurid, Erdtracht Bernard, Berrouschot Jörg, "Rheopheresis: Rheologic, Functional, and Structural Aspects", Therapeutic Apheresis, US , (20001001), vol. 4, no. 5, doi:10.1046/j.1526-0968.2000.004005348.x, ISSN 1091-6660, pages 348 - 357, XP093245557
OPPOSITION- Mann K. G. et al, "Citrate anticoagulation and the dynamics of thrombin generation", JOURNAL OF THROMBOSIS AND HAEMOSTASIS, BLACKWELL PUBLISHING, OXFORD, GB, GB , (20071001), vol. 5, no. 10, doi:10.1111/j.1538-7836.2007.02710.x, ISSN 1538-7933, pages 2055 - 2061, XP093272185
OPPOSITION- Koh M. B., Lee Y. S., Chay J., "Appropriate blood component usage", ISBT Science Series, (20111201), vol. 6, no. 2, doi:10.1111/j.1751-2824.2011.01540.x, ISSN 1751-2816, pages 249 - 256, XP093272175
OPPOSITION- Mast Alan E. et al, "Solvent/Detergent-Treated Plasma Has Decreased Antitrypsin Activity and Absent Antiplasmin Activity", Blood, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL, (19991201), vol. 94, no. 11, doi:10.1182/blood.V94.11.3922.423k33_3922_3927, ISSN 0006-4971, pages 3922 - 3927, XP093272191

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents